← All updates

NewSpring Capital

NewSpring says Honest Health raised $140 million with NewSpring leading

February 26, 2026 primary Manager profile

Summary: NewSpring Capital reported that Honest Health raised $140 million and that NewSpring led the investment. The healthcare and value-based-care descriptions are attributed to NewSpring's February 26, 2026 announcement.

Why it matters: A lead investment in a healthcare operating company is a public signal about NewSpring's sector focus and platform-building activity, useful for diligence questions about healthcare exposure and portfolio construction.

9AT filing context: Public ADV context maps NewSpring Capital to CRD 160608 / SEC file 801-73849 with about $3.3B in reported regulatory AUM. 13F data is not central to this private-company investment item.

Summary

NewSpring Capital reported that Honest Health raised $140 million and that NewSpring led the investment. The source is NewSpring’s own announcement dated February 26, 2026. The healthcare, value-based-care, and company-growth descriptions should remain attributed to NewSpring and the announcement.

Why it matters

For due-diligence readers, a lead investment in a healthcare operating company is a public signal about NewSpring’s sector activity and portfolio-building posture. It can support follow-up questions about healthcare specialization, operating partner involvement, thesis concentration, and how the investment fits within the firm’s broader strategy mix.

Source notes

9AT filing context

Public ADV context maps NewSpring Capital to CRD 160608 / SEC file 801-73849, with about $3.3 billion in reported regulatory AUM. Because this is a private-company financing item, 13F data is not a useful primary lens; the filing context is limited to adviser identity and public platform scale.

What to watch

Watch for follow-on financing, portfolio-company operating updates, healthcare-platform add-ons, and future ADV updates that clarify NewSpring’s reported adviser and private-fund footprint.

Source links